✦ LIBER ✦

Neoadjuvant (preoperative) chemotherapy for breast cancer

✍ Scribed by Joseph Ragaz; Robert Baird; Patricia Rebbeck; James Goldie; Andrew Coldman; John Spinelli

Publisher: John Wiley and Sons
Year: 1985
Tongue: English
Weight: 556 KB
Volume: 56
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19850815)56:4<719::aid-cncr2820560403>3.0.co;2-w

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neoadjuvant chemotherapy for operable br

Neoadjuvant chemotherapy for operable breast cancer

✍ J. S. D. Mieog; J. A. van der Hage; C. J. H. van de Velde 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB 👁 2 views

Preoperative chemotherapy for fungating

Preoperative chemotherapy for fungating breast cancer

✍ Dr. Anand Kumar; L. L. Shah; Sushila Khanna; N. N. Khanna 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 327 KB

Thirty cases of fungating breast cancer (stages 111 and IV) were treated preoperatively by combination chemotherapy using cyclophosphamide (Endoxan), methotrexate, 5-fluorouracil, and prednisone. Mastectomy was performed after 2 cycles of preoperative chemotherapy followed by 6 more cycles postopera

Neoadjuvant chemotherapy in breast cance

Neoadjuvant chemotherapy in breast cancer

✍ H. Charfare; S. Limongelli; A. D. Purushotham 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB 👁 2 views

Residual specimen cellularity after neoa

Residual specimen cellularity after neoadjuvant chemotherapy for breast cancer

✍ F. Peintinger; H. M. Kuerer; S. E. McGuire; R. Bassett; L. Pusztai; W. F. Symman 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB 👁 2 views

## Abstract ## Background Neoadjuvant chemotherapy for breast cancer reduces tumour cellularity, the percentage of the primary tumour area that is composed of invasive tumour cells. Minimal residual tumour cellularity (5 per cent or less of tumour area composed of invasive tumour cells) may be ass

Neoadjuvant chemotherapy in locally adva

Neoadjuvant chemotherapy in locally advanced breast cancer

✍ Singh, Gurpreet; Singh, Deepinder P.; Gupta, Devender; Muralikrishna, Bhavaraju 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 403 KB 👁 2 views

Thirty-eight patients with locally advanced breast cancer (Stage HI) were treated over a 3-year period. All patients initially received two cycles of CMF (cyclophosphamide, 100 mg/m2 p.0. dl-14; methotrexate 40mg/m2 intravenously (iv), d l and d8., 5 Fluorouracil 500 mg/m2 iv d l and d8). They were

Neoadjuvant therapy for breast cancer

✍ Stephen V. Liu; Laleh Melstrom; Kathy Yao; Christy A. Russell; Stephen F. Sener 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB